E Bluhmki
Overview
Explore the profile of E Bluhmki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
2571
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Solzin J, Eppler K, Knapp B, Buchner H, Bluhmki E
SLAS Discov
. 2022 Nov;
28(1):29-38.
PMID: 36415004
For process optimisation Design of Experiments (DoE) has long been established as a more powerful strategy than a One Factor at a Time approach. Nevertheless, DoE is not widely used...
2.
Hajjar K, Fulton R, Diener H, Lees K, Alexandrov A, Bath P, et al.
Int J Stroke
. 2012 Jul;
8(8):652-6.
PMID: 22813096
Background: Although the established measure of disability post stroke, the modified Rankin Scale emphasizes motor function and may underestimate the importance of cognitive impairment in more disabled patients. A subset...
3.
Weimar C, Ali M, Lees K, Bluhmki E, Donnan G, Diener H
Int J Stroke
. 2010 May;
5(2):103-9.
PMID: 20446944
Background: The Virtual International Stroke Trials Archive was established to improve stroke care and trial design through the collation, categorization and potential access to data sets from clinical trials for...
4.
Spohr F, Arntz H, Bluhmki E, Bode C, Carli P, Chamberlain D, et al.
Eur J Clin Invest
. 2005 Apr;
35(5):315-23.
PMID: 15860043
Prehospital cardiac arrest has been associated with a very poor prognosis. Acute myocardial infarction and massive pulmonary embolism are the underlying causes of out-of-hospital cardiac arrest in 50-70% of patients....
5.
Lesaffre E, Bluhmki E, BERIOLI S, Danays T, Fox N, Van de Werf F
Eur Heart J
. 2001 Jun;
22(11):898-902.
PMID: 11428813
No abstract available.
6.
Berger C, Fiorelli M, Steiner T, Schabitz W, Bozzao L, Bluhmki E, et al.
Stroke
. 2001 Jun;
32(6):1330-5.
PMID: 11387495
Background And Purpose: The term symptomatic hemorrhage secondary to ischemic stroke implies a clear causal relationship between clinical deterioration and hemorrhagic transformation (HT) regardless of the type of HT. The...
7.
Euller-Ziegler L, Velicitat P, Bluhmki E, Turck D, Scheuerer S, Combe B
Inflamm Res
. 2001 May;
50 Suppl 1:S5-9.
PMID: 11339521
This paper reviews published studies on the intramuscular use of meloxicam in acute rheumatic conditions. Data were obtained from 68 healthy volunteers and >800 patients with conditions such as arthritis,...
8.
Combe B, Velicitat P, Garzon N, Bluhmki E
Inflamm Res
. 2001 May;
50 Suppl 1:S10-6.
PMID: 11339515
Objective: This double-blind, double-dummy, two-way comparative trial evaluated the overall efficacy and tolerability of intramuscular (im) vs oral meloxicam. Subjects: 346 patients with rheumatoid arthritis (RA). Treatment And Methods: 173...
9.
Stingele R, Bluhmki E, Hacke W
Cerebrovasc Dis
. 2001 Feb;
11(1):30-3.
PMID: 11173791
Unlabelled: The results of the Second European-Australasian Acute Stroke Study (ECASS II) were negative with respect to the primary endpoint. This post hoc analysis of ECASS II data was designed...
10.
Larrue V, von Kummer R R, Muller A, Bluhmki E
Stroke
. 2001 Feb;
32(2):438-41.
PMID: 11157179
Background And Purpose: Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) improves the outcome for ischemic stroke patients who can be treated within 3 hours of symptom onset. The efficacy...